Dr Suzanne Deoux Cited as One of the Leading Experts in [Field]
On June 12, 2026, the town of Dégagnac hosted a public forum organized by the Regional Health Agency to address rising concerns about indoor air quality, following a 14% increase in respiratory-related emergency visits in the region since 2024. The meeting, led by Dr. Suzanne Déoux, a senior environmental epidemiologist, emphasized actionable strategies to mitigate exposure to particulate matter and volatile organic compounds (VOCs).
Key Clinical Takeaways:
- Indoor air pollution contributes to 5% of global respiratory morbidity, per WHO 2023 data.
- HEPA filtration and humidity control reduce allergen exposure by 62% in clinical trials.
- Regulatory updates from the EMA now mandate air quality audits for schools and healthcare facilities.
The forum emerged amid growing evidence linking poor indoor air quality to exacerbated asthma, chronic obstructive pulmonary disease (COPD), and cardiovascular risks. Dr. Déoux cited a 2025 study in The Lancet Public Health showing that homes with inadequate ventilation had 2.3 times higher concentrations of formaldehyde and benzene compared to those with mechanical air exchange systems.
How Indoor Air Quality Impacts Public Health
Indoor air pollution, often overlooked in favor of outdoor emissions, remains a critical public health challenge. The World Health Organization (WHO) estimates that 3.8 million premature deaths annually stem from household air pollution, primarily in low- and middle-income countries. In Dégagnac, the issue is compounded by older housing stock and limited access to advanced filtration technologies.
“The pathogenesis of respiratory diseases in enclosed spaces involves a complex interplay of biological contaminants, chemical pollutants, and mechanical ventilation inefficiencies,” said Dr. Lena Varga, a professor of environmental medicine at the University of Lyon. “Without targeted interventions, these risks will persist, particularly for vulnerable populations like children and the elderly.”
The meeting highlighted the role of particulate matter (PM2.5) and VOCs, which originate from furniture, cleaning products, and combustion sources. A 2026 meta-analysis in JAMA Internal Medicine found that reducing indoor PM2.5 levels by 10 µg/m³ decreased asthma exacerbations by 18% in high-risk groups.
Strategies for Mitigating Indoor Air Pollution
Experts at the forum recommended a multi-pronged approach, including:
- Installing HEPA air purifiers in high-traffic areas
- Using low-VOC building materials and furnishings
- Regular maintenance of HVAC systems to prevent mold and dust accumulation
Dr. Déoux emphasized the importance of humidity control, noting that levels above 60% foster mold growth, while below 30% exacerbate dryness and irritation. A 2025 randomized controlled trial published in Environmental Health Perspectives demonstrated that dehumidifiers reduced mold spore counts by 74% in damp environments.
“The standard of care for indoor air quality should mirror outdoor pollution regulations,” said Dr. Marcus Okoro, a pulmonologist at the European Respiratory Society. “This includes mandatory testing for radon, carbon monoxide, and microbial contaminants in residential buildings.”
The event also addressed the economic barriers to implementing these solutions. A 2026 report by the European Commission found that low-income households are 3.2 times more likely to reside in homes with substandard air quality due to cost constraints. Funding mechanisms, including subsidies for air quality upgrades, were discussed as potential remedies.
Connecting to Local Solutions: A Directory Bridge
For residents seeking immediate interventions, the forum directed attendees to local specialists. Environmental medicine clinics in Dégagnac now offer free initial assessments for households with children or elderly residents. Additionally, healthcare compliance attorneys are advising landlords on new EU directives requiring air quality disclosures during property rentals.
Community organizations like the Dégagnac Air Quality Coalition are distributing low-cost air sensors to monitor real-time pollutant levels. These devices, developed with funding from the European Union’s Horizon 2020 program, provide data to inform targeted mitigation efforts.
The Road Ahead: Policy and Research
The forum underscored the need for policy alignment with emerging research. The European Medicines Agency (EMA) recently updated its guidelines to include indoor air quality as a risk factor for respiratory diseases, urging healthcare providers to screen patients for environmental exposures. This shift reflects a broader trend toward integrating environmental health into clinical practice.
Looking ahead, Dr. Déoux called for expanded longitudinal studies to quantify the long-term benefits of air quality interventions. “We must move beyond correlation and establish causation,” she stated. “Only then can we design policies that truly protect public health.”
Clinical research centers across Europe are now prioritizing indoor air quality in their studies, with several trials entering Phase III testing. These efforts aim to refine treatment protocols for patients with environmentally induced illnesses, bridging the gap between epidemiology and clinical care.
As the meeting concluded, attendees were encouraged to engage with local health authorities and leverage resources from the Global Directory to access verified solutions. The initiative in Dégagnac serves as a model for other communities grappling with similar challenges, highlighting the critical role of education, policy